TS-1® Capsule received TW NHI approval for Treatment of Patients with Locally Advanced or Metastatic Non-small Cell Lung Cancer
2020.1.31
最新消息
...
LONSURF® get NHI reimbursement for metastatic colorectal cancer treatment since Dec/01/2018.
2018.11.16
最新消息
...
TS-1® Capsule approved in Taiwan for the Treatment of Patients with Locally Advanced or Metastatic Non-small Cell Lung Cancer.
2018.9.12
最新消息
...
TTY Biopharm and Taiho Pharmaceutical entered in an exclusive agreement of LONSURF® has received license approval from TFDA.
2018.1.15
最新消息
...
Mr. Rongjin Lin has been sentenced with an execution of ten years in prison, and the confiscation of illegal earnings.
2017.9.1
最新消息
...
MolMed and TTY Biopharm entered into an exclusive agreement to commercialise Zalmoxis® in certain Asian territories
2017.6.30
最新消息
...
MolMed and TTY Biopharm entered into a term sheet to commercialise Zalmoxis® in certain Asian territories
2017.2.8
最新消息
...
Overcame Barriers- Anticancer Agent S-1 Capsule (S-1) Received Reimbursement for Treatment of Gastric Cancer
2016.12.13
最新消息
...
TTY Biopharm’s Anticancer Agent S-1 Received Reimbursement for Adjuvant Treatment of Locally-advanced Gastric Cancer
2016.12.13
最新消息
...
TTY Biopharm received an exclusive license from Taiho Pharmaceutical to sell an anticancer drug in Taiwan market
2016.10.18
最新消息
...